100 related articles for article (PubMed ID: 33542481)
1. Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT.
Esteve J; Giebel S; Labopin M; Czerw T; Wu D; Volin L; Socié G; Yakoub-Agha I; Maertens J; Cornelissen JJ; Pigneux A; Shimoni A; Schwerdtfeger R; Labussière-Wallet H; Russell N; Schattenberg A; Chevallier P; Koza V; Foà R; Schmid C; Peric Z; Mohty M; Nagler A
Leukemia; 2021 Aug; 35(8):2232-2242. PubMed ID: 33542481
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
Kim R; Bergugnat H; Pastoret C; Pasquier F; Raffoux E; Larcher L; Passet M; Grardel N; Delabesse E; Kubetzko S; Caye-Eude A; Meyer C; Marschalek R; Lafage-Pochitaloff M; Thiebaut-Bertrand A; Balsat M; Escoffre-Barbe M; Blum S; Baumann M; Banos A; Straetmans N; Gallego-Hernanz MP; Chalandon Y; Graux C; Soulier J; Leguay T; Hunault M; Huguet F; Lhéritier V; Dombret H; Boissel N; Clappier E
Blood; 2023 Nov; 142(21):1806-1817. PubMed ID: 37595275
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation.
Sayyed A; Chen C; Gerbitz A; Kim DDH; Kumar R; Lam W; Law AD; Lipton JH; Michelis FV; Novitzky-Basso I; Viswabandya A; Mattsson J; Pasic I
Transplant Cell Ther; 2024 May; 30(5):520.e1-520.e12. PubMed ID: 38462215
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation.
Lucero J; Alhumaid M; Novitzky-Basso I; Capo-Chichi JM; Stockley T; Gupta V; Bankar A; Chan S; Schuh AC; Minden M; Mattsson J; Kumar R; Sibai H; Tierens A; Kim DDH
Ann Hematol; 2024 Apr; 103(4):1187-1196. PubMed ID: 38291275
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring
Jiang B; Zhao Y; Luo Y; Yu J; Chen Y; Ye B; Fu H; Lai X; Liu L; Ye Y; Zheng W; Sun J; He J; Zhao Y; Wei G; Cai Z; Huang H; Shi J
Cell Transplant; 2024; 33():9636897231225821. PubMed ID: 38270130
[No Abstract] [Full Text] [Related]
6. Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing Prediction of Clinical Outcomes From a Single-Center Study.
Ashouri K; Nittur V; Ginosyan AA; Hwang J; Adnani B; Chen D; Savitala-Damerla L; Schiff K; Chaudhary P; Kovach AE; Ladha A; Siddiqi I; Ali A; Woan K; Tam E; Yaghmour G
Clin Lymphoma Myeloma Leuk; 2024 Mar; 24(3):e59-e66.e2. PubMed ID: 38061959
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of end of induction measurable residual disease monitoring in B-cell acute lymphoblastic leukemia: A single center experience.
Arunachalam AK; Selvarajan S; Mani T; Janet NB; Maddali M; Lionel SA; Kulkarni U; Korula A; Aboobacker FN; Abraham A; George B; Balasubramanian P; Mathews V
Cytometry B Clin Cytom; 2023 Nov; 104(6):440-452. PubMed ID: 37555390
[TBL] [Abstract][Full Text] [Related]
8. Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.
Percival ME; Wang HL; Zhang MJ; Saber W; de Lima M; Litzow M; Kebriaei P; Abdel-Azim H; Adekola K; Aljurf M; Bacher U; Badawy SM; Beitinjaneh A; Bejanyan N; Bhatt V; Byrne M; Cahn JY; Castillo P; Chao N; Chhabra S; Copelan E; Cutler C; DeFilipp Z; Dias A; Diaz MA; Estey E; Farhadfar N; Frangoul HA; Freytes CO; Gale RP; Ganguly S; Gowda L; Grunwald M; Hossain N; Kamble RT; Kanakry CG; Kansagra A; Kharfan-Dabaja MA; Krem M; Lazarus HM; Lee JW; Liesveld JL; Lin R; Liu H; McGuirk J; Munker R; Murthy HS; Nathan S; Nishihori T; Olsson RF; Palmisiano N; Passweg JR; Prestidge T; Ringdén O; Rizzieri DA; Rybka WB; Savoie ML; Schultz KR; Seo S; Sharma A; Solh M; Strair R; van der Poel M; Verdonck LF; Yared JA; Weisdorf D; Sandmaier BM
Bone Marrow Transplant; 2021 Sep; 56(9):2108-2117. PubMed ID: 33864019
[TBL] [Abstract][Full Text] [Related]
9. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
[No Abstract] [Full Text] [Related]
10. Current assessment and management of measurable residual disease in patients with acute lymphoblastic leukemia in the setting of CAR-T-cell therapy.
Lin M; Zhao X; Chang Y; Zhao X
Chin Med J (Engl); 2024 Jan; 137(2):140-151. PubMed ID: 38148315
[TBL] [Abstract][Full Text] [Related]
11. Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Stahl M; Derkach A; Farnoud N; Bewersdorf JP; Robinson T; Famulare C; Cho C; Devlin S; Menghrajani K; Patel MA; Cai SF; Miles LA; Bowman RL; Geyer MB; Dunbar A; Epstein-Peterson ZD; McGovern E; Schulman J; Glass JL; Taylor J; Viny AD; Stein EM; Getta B; Arcila ME; Gao Q; Barker J; Shaffer BC; Papadopoulos EB; Gyurkocza B; Perales MA; Abdel-Wahab O; Levine RL; Giralt SA; Zhang Y; Xiao W; Pai N; Papaemmanuil E; Tallman MS; Roshal M; Goldberg AD
Am J Hematol; 2023 Jan; 98(1):79-89. PubMed ID: 36251406
[TBL] [Abstract][Full Text] [Related]
12. Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation.
Dimitriou M; Mortera-Blanco T; Tobiasson M; Mazzi S; Lehander M; Högstrand K; Karimi M; Walldin G; Jansson M; Vonlanthen S; Ljungman P; Langemeijer S; Yoshizato T; Hellström-Lindberg E; Woll PS; Jacobsen SEW
Blood; 2024 Mar; 143(11):953-966. PubMed ID: 38096358
[TBL] [Abstract][Full Text] [Related]
13. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
Buldini B; Varotto E; Maurer-Granofszky M; Gaipa G; Schumich A; Brüggemann M; Mejstrikova E; Cazzaniga G; Hrusak O; Szczepanowski M; Scarparo P; Zimmermann M; Strehl S; Schinnerl D; Zaliova M; Karawajew L; Bourquin JP; Feuerstein T; Cario G; Alten J; Möricke A; Biffi A; Parasole R; Fagioli F; Valsecchi MG; Biondi A; Locatelli F; Attarbaschi A; Schrappe M; Conter V; Basso G; Dworzak MN
Blood; 2024 Apr; 143(17):1738-1751. PubMed ID: 38215390
[TBL] [Abstract][Full Text] [Related]
14. A prognostic score system in adult T-cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation.
Xiao M; Zhou J; Zhu X; He Y; Wang F; Zhang Y; Mo X; Han W; Wang J; Wang Y; Chen H; Chen Y; Zhao X; Chang Y; Xu L; Liu K; Huang X; Zhang X
Bone Marrow Transplant; 2024 Apr; 59(4):496-504. PubMed ID: 38267585
[TBL] [Abstract][Full Text] [Related]
15. Co-culture model of B-cell acute lymphoblastic leukemia recapitulates a transcription signature of chemotherapy-refractory minimal residual disease.
Rellick SL; Hu G; Piktel D; Martin KH; Geldenhuys WJ; Nair RR; Gibson LF
Sci Rep; 2021 Aug; 11(1):15840. PubMed ID: 34349149
[TBL] [Abstract][Full Text] [Related]
16. Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remission.
Jabbour E; Haddad FG; Short NJ; Senapati J; Jain N; Sasaki K; Jorgensen J; Wang SA; Alvarado Y; Wang X; DiNardo C; Masarova L; Kadia T; Garris RS; Ravandi F; Kantarjian H
Blood; 2024 Feb; 143(5):417-421. PubMed ID: 37879077
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic obesity syndrome: rare presentation of CNS+ B-cell lymphoblastic lymphoma.
Quigg TC; Haddad NG; Buchsbaum JC; Shih CS
Pediatr Blood Cancer; 2012 Nov; 59(5):930-3. PubMed ID: 22213612
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia.
Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study.
Loke J; Labopin M; Craddock C; Socié G; Gedde-Dahl T; Blaise D; Forcade E; Salmenniemi U; Huynh A; Versluis J; Yakoub-Agha I; Labussière-Wallet H; Maertens J; Passweg J; Bulabois CE; Gabellier L; Mielke S; Castilla-Llorente C; Deconinck E; Brissot E; Nagler A; Ciceri F; Mohty M
Cancer; 2024 Apr; ():. PubMed ID: 38581695
[TBL] [Abstract][Full Text] [Related]
20. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Children: A Retrospective Cohort Study at a Pediatric Oncology Center.
Maia Moço L; Fraga A; Maia I; Almeida M
Cureus; 2024 Feb; 16(2):e54154. PubMed ID: 38496108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
